vs

Side-by-side financial comparison of Axil Brands, Inc. (AXIL) and CHICAGO RIVET & MACHINE CO (CVR). Click either name above to swap in a different company.

Axil Brands, Inc. is the larger business by last-quarter revenue ($8.1M vs $6.0M, roughly 1.4× CHICAGO RIVET & MACHINE CO). Axil Brands, Inc. runs the higher net margin — 8.7% vs -19.3%, a 28.0% gap on every dollar of revenue. On growth, CHICAGO RIVET & MACHINE CO posted the faster year-over-year revenue change (45.9% vs 5.2%). Axil Brands, Inc. produced more free cash flow last quarter ($906.4K vs $24.3K). Over the past eight quarters, Axil Brands, Inc.'s revenue compounded faster (12.1% CAGR vs -12.7%).

Axil Brands, Inc. is a U.S.-headquartered company that designs, manufactures and markets premium hearing protection products, audio enhancement devices and personal audio accessories. Its offerings include custom-fit earplugs, Bluetooth-enabled hearing buds for work, sports and leisure use, serving both consumer and professional segments across global markets.

Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.

AXIL vs CVR — Head-to-Head

Bigger by revenue
AXIL
AXIL
1.4× larger
AXIL
$8.1M
$6.0M
CVR
Growing faster (revenue YoY)
CVR
CVR
+40.7% gap
CVR
45.9%
5.2%
AXIL
Higher net margin
AXIL
AXIL
28.0% more per $
AXIL
8.7%
-19.3%
CVR
More free cash flow
AXIL
AXIL
$882.1K more FCF
AXIL
$906.4K
$24.3K
CVR
Faster 2-yr revenue CAGR
AXIL
AXIL
Annualised
AXIL
12.1%
-12.7%
CVR

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
AXIL
AXIL
CVR
CVR
Revenue
$8.1M
$6.0M
Net Profit
$704.9K
$-1.2M
Gross Margin
68.1%
2.7%
Operating Margin
11.1%
-15.3%
Net Margin
8.7%
-19.3%
Revenue YoY
5.2%
45.9%
Net Profit YoY
11.2%
68.0%
EPS (diluted)
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXIL
AXIL
CVR
CVR
Q4 25
$8.1M
$6.0M
Q3 25
$6.9M
$7.4M
Q2 25
$5.8M
$7.3M
Q1 25
$6.9M
$7.2M
Q4 24
$7.7M
$4.1M
Q3 24
$5.9M
$7.0M
Q2 24
$6.5M
$8.1M
Q1 24
$6.5M
$7.9M
Net Profit
AXIL
AXIL
CVR
CVR
Q4 25
$704.9K
$-1.2M
Q3 25
$334.3K
$67.6K
Q2 25
$-245.6K
$-395.0K
Q1 25
$576.7K
$401.0K
Q4 24
$633.7K
$-3.6M
Q3 24
$-109.8K
$-1.4M
Q2 24
$49.5K
$142.1K
Q1 24
$781.1K
$-698.0K
Gross Margin
AXIL
AXIL
CVR
CVR
Q4 25
68.1%
2.7%
Q3 25
67.6%
18.1%
Q2 25
70.0%
13.4%
Q1 25
71.7%
22.9%
Q4 24
71.1%
-43.7%
Q3 24
71.0%
10.0%
Q2 24
71.5%
17.6%
Q1 24
71.5%
9.5%
Operating Margin
AXIL
AXIL
CVR
CVR
Q4 25
11.1%
-15.3%
Q3 25
6.0%
0.9%
Q2 25
0.8%
-5.7%
Q1 25
8.4%
1.0%
Q4 24
8.7%
-86.4%
Q3 24
-2.4%
-11.8%
Q2 24
2.6%
1.3%
Q1 24
-1.6%
-11.5%
Net Margin
AXIL
AXIL
CVR
CVR
Q4 25
8.7%
-19.3%
Q3 25
4.9%
0.9%
Q2 25
-4.3%
-5.4%
Q1 25
8.3%
5.5%
Q4 24
8.2%
-88.0%
Q3 24
-1.9%
-20.8%
Q2 24
0.8%
1.8%
Q1 24
12.1%
-8.9%
EPS (diluted)
AXIL
AXIL
CVR
CVR
Q4 25
$0.09
Q3 25
$0.04
Q2 25
$-0.03
Q1 25
$0.07
Q4 24
$0.08
Q3 24
$-0.02
Q2 24
$0.11
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXIL
AXIL
CVR
CVR
Cash + ST InvestmentsLiquidity on hand
$5.0M
$1.7M
Total DebtLower is stronger
$138.3K
Stockholders' EquityBook value
$11.1M
$18.8M
Total Assets
$16.2M
$23.3M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXIL
AXIL
CVR
CVR
Q4 25
$5.0M
$1.7M
Q3 25
$4.1M
$1.7M
Q2 25
$4.8M
$1.2M
Q1 25
$4.7M
$765.6K
Q4 24
$5.2M
$2.2M
Q3 24
$4.1M
$2.2M
Q2 24
$3.3M
$2.6M
Q1 24
$4.9M
$2.7M
Total Debt
AXIL
AXIL
CVR
CVR
Q4 25
$138.3K
Q3 25
$139.2K
Q2 25
$140.2K
Q1 25
$141.0K
Q4 24
$143.3K
$0
Q3 24
$144.3K
Q2 24
$146.6K
Q1 24
Stockholders' Equity
AXIL
AXIL
CVR
CVR
Q4 25
$11.1M
$18.8M
Q3 25
$10.2M
$20.0M
Q2 25
$9.7M
$20.0M
Q1 25
$9.7M
$20.4M
Q4 24
$8.8M
$20.0M
Q3 24
$7.9M
$23.7M
Q2 24
$7.7M
$25.2M
Q1 24
$8.8M
$25.2M
Total Assets
AXIL
AXIL
CVR
CVR
Q4 25
$16.2M
$23.3M
Q3 25
$15.4M
$24.0M
Q2 25
$12.9M
$23.6M
Q1 25
$13.0M
$24.1M
Q4 24
$13.7M
$23.4M
Q3 24
$11.4M
$26.4M
Q2 24
$11.0M
$27.3M
Q1 24
$12.7M
$27.8M
Debt / Equity
AXIL
AXIL
CVR
CVR
Q4 25
0.01×
Q3 25
0.01×
Q2 25
0.01×
Q1 25
0.01×
Q4 24
0.02×
0.00×
Q3 24
0.02×
Q2 24
0.02×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXIL
AXIL
CVR
CVR
Operating Cash FlowLast quarter
$934.8K
$116.4K
Free Cash FlowOCF − Capex
$906.4K
$24.3K
FCF MarginFCF / Revenue
11.1%
0.4%
Capex IntensityCapex / Revenue
0.3%
1.5%
Cash ConversionOCF / Net Profit
1.33×
TTM Free Cash FlowTrailing 4 quarters
$-1.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXIL
AXIL
CVR
CVR
Q4 25
$934.8K
$116.4K
Q3 25
$-739.2K
$638.0K
Q2 25
$194.4K
$28.2K
Q1 25
$-169.9K
$-2.0M
Q4 24
$1.0M
$-60.1K
Q3 24
$897.3K
$-58.2K
Q2 24
$-336.6K
$363.5K
Q1 24
$-912.8K
$-398.8K
Free Cash Flow
AXIL
AXIL
CVR
CVR
Q4 25
$906.4K
$24.3K
Q3 25
$-747.6K
$492.1K
Q2 25
$-22.8K
Q1 25
$-258.2K
$-2.1M
Q4 24
$941.1K
$-118.1K
Q3 24
$-368.9K
Q2 24
$-394.9K
$58.0K
Q1 24
$-922.1K
$-491.8K
FCF Margin
AXIL
AXIL
CVR
CVR
Q4 25
11.1%
0.4%
Q3 25
-10.9%
6.7%
Q2 25
-0.3%
Q1 25
-3.7%
-28.3%
Q4 24
12.2%
-2.9%
Q3 24
-5.3%
Q2 24
-6.1%
0.7%
Q1 24
-14.3%
-6.3%
Capex Intensity
AXIL
AXIL
CVR
CVR
Q4 25
0.3%
1.5%
Q3 25
0.1%
2.0%
Q2 25
0.7%
Q1 25
1.3%
0.6%
Q4 24
0.9%
1.4%
Q3 24
4.5%
Q2 24
0.9%
3.8%
Q1 24
0.1%
1.2%
Cash Conversion
AXIL
AXIL
CVR
CVR
Q4 25
1.33×
Q3 25
-2.21×
9.44×
Q2 25
Q1 25
-0.29×
-5.01×
Q4 24
1.59×
Q3 24
Q2 24
-6.80×
2.56×
Q1 24
-1.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXIL
AXIL

Hearing Enhancement And Protection$7.8M95%
Other$378.9K5%

CVR
CVR

Fastener$5.1M85%
Other$890.7K15%

Related Comparisons